Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis
Introduction. Glucocorticoid-induced osteoporosis (GIOP) is a bone metabolic disease that develops as a result of glucocorticoid (GC) use, is one of the most frequent causes of secondary osteoporosis, leads to an increase in the risk of low-energy fractures, disability and mortality of GC users. Des...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaslavsky O.Yu.
2024-09-01
|
| Series: | Bolʹ, Sustavy, Pozvonočnik |
| Subjects: | |
| Online Access: | https://pjs.zaslavsky.com.ua/index.php/journal/article/view/426 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850195756804210688 |
|---|---|
| author | N.V. Grygorieva V.M. Kovalenko М.О. Коrzh M.D. Tronko I.Yu. Golovach N.V. Dedukh D.G. Rekalov S.S. Strafun S.I. Smiyan O.A. Golubovska Ya.O. Dziublyk N.V. Kharchenko G.O. Protsenko O.O. Garmish V.L. Orlenko F.V. Klymovytsky А.S. Musiіenko T.A. Karasevska |
| author_facet | N.V. Grygorieva V.M. Kovalenko М.О. Коrzh M.D. Tronko I.Yu. Golovach N.V. Dedukh D.G. Rekalov S.S. Strafun S.I. Smiyan O.A. Golubovska Ya.O. Dziublyk N.V. Kharchenko G.O. Protsenko O.O. Garmish V.L. Orlenko F.V. Klymovytsky А.S. Musiіenko T.A. Karasevska |
| author_sort | N.V. Grygorieva |
| collection | DOAJ |
| description | Introduction. Glucocorticoid-induced osteoporosis (GIOP) is a bone metabolic disease that develops as a result of glucocorticoid (GC) use, is one of the most frequent causes of secondary osteoporosis, leads to an increase in the risk of low-energy fractures, disability and mortality of GC users. Despite the few studies conducted in Ukraine on the epidemiology and treatment of GIOP, there have been no national recommendations for its management until now, which has become the background for their creation. The purpose was to develop national guidelines for the diagnosis, prevention, and treatment of GIOP based on the analytical analysis of modern literary sources to improve the awareness of the medical community of Ukraine, improve management, and reduce the socio-economic burden of the disease. Materials and methods. A group of 18 experts, leading Ukrainian scientists in various fields, was created to develop the guideline. An analysis of current literary sources on epidemiology, risk factors, diagnosis, prevention and treatment of GIOP, and monitoring of the effectiveness and safety of its treatment was carried out. Evidence was synthesized using the GRADE system, and a critical assessment of the quality of the recommendations was carried out using the AGREE II tool. Results. The guideline consists of 12 provisions on screening, diagnosis, prevention, and treatment of GIOP. The authors emphasized the need to increase the awareness of the medical community of Ukraine regarding the problem, as well as patients regarding the possible side effects of GC. They presented the features of the clinical assessment of the osteoporotic fracture risk in GC users, as well as modern and available in Ukraine methods of diagnosis and treatment of GIOP. Conclusion. The first Ukrainian guideline for screening, diagnosis, prevention, and treatment of GIOP is an important national tool for its management, which is recommended by the Board of the Ukrainian Association of Osteoporosis for use in practical health care by doctors of various specialties. |
| format | Article |
| id | doaj-art-559ff87ae9ab4246a2b2e31110cadb8a |
| institution | OA Journals |
| issn | 2224-1507 2307-1133 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | Zaslavsky O.Yu. |
| record_format | Article |
| series | Bolʹ, Sustavy, Pozvonočnik |
| spelling | doaj-art-559ff87ae9ab4246a2b2e31110cadb8a2025-08-20T02:13:40ZengZaslavsky O.Yu.Bolʹ, Sustavy, Pozvonočnik2224-15072307-11332024-09-0114310713210.22141/pjs.14.3.2024.426426Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosisN.V. Grygorieva0https://orcid.org/0000-0002-4266-461XV.M. Kovalenko1https://orcid.org/0000-0003-3802-9207М.О. Коrzh2https://orcid.org/0000-0002-0489-3104M.D. Tronko3https://orcid.org/0000-0001-7421-0981I.Yu. Golovach4https://orcid.org/0000-0002-6930-354XN.V. Dedukh5https://orcid.org/0000-0003-0307-2328D.G. Rekalov6https://orcid.org/0000-0002-5793-2322S.S. Strafun7https://orcid.org/0000-0001-8178-9290S.I. Smiyan8https://orcid.org/0000-0001-5543-9895O.A. Golubovska9https://orcid.org/0000-0003-3455-8718Ya.O. Dziublyk10https://orcid.org/0000-0002-6497-5267N.V. Kharchenko11https://orcid.org/0000-0002-6683-3748G.O. Protsenko12https://orcid.org/0000-0001-9328-4839O.O. Garmish13https://orcid.org/0000-0001-8713-253XV.L. Orlenko14https://orcid.org/0000-0002-8400-576XF.V. Klymovytsky15https://orcid.org/0000-0002-0566-5808А.S. Musiіenko16https://orcid.org/0000-0002-1672-1991T.A. Karasevska17https://orcid.org/0000-0003-3687-6218State Institution “D.F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine”, Kyiv, UkraineState Institution “National Scientific Center “The M.D. Strazhesko Institute of cardiology, clinical and regenerative medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, UkraineState Institution “Sytenko Institute of Spine and Joint Pathology of National Academy of Medical Sciences of Ukraine”, Kharkiv, Ukraine; Kharkiv National Medical University, Kharkiv, UkraineState Institution “V.P. Komisarenko Institute of Endocrinology and Metabolism”, Kyiv, UkraineFeofania Clinical Hospital of the State Administration of Affairs, KyivState Institution “D.F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine”, Kyiv, UkraineState Institution “National Scientific Center “The M.D. Strazhesko Institute of cardiology, clinical and regenerative medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, UkraineState Institution “The Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine”, Kyiv, UkraineI. Horbachevsky Ternopil National Medical University, Ternopil, UkraineBogomolets National Medical University, Kyiv, UkraineState Institution “National institute of phthisiology and pulmonology named after F.G. Yanovsky NAMS of Ukraine”, Kyiv, UkraineShupyk National Healthcare University of Ukraine, Kyiv, UkraineState Institution “National Scientific Center “The M.D. Strazhesko Institute of cardiology, clinical and regenerative medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, UkraineState Institution “National Scientific Center “The M.D. Strazhesko Institute of cardiology, clinical and regenerative medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv, UkraineState Institution “V.P. Komisarenko Institute of Endocrinology and Metabolism”, Kyiv, UkraineDonetsk National Medical University, Kropyvnytskyi, UkraineState Institution “D.F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine”, Kyiv, UkraineBogomolets National Medical University, Kyiv, UkraineIntroduction. Glucocorticoid-induced osteoporosis (GIOP) is a bone metabolic disease that develops as a result of glucocorticoid (GC) use, is one of the most frequent causes of secondary osteoporosis, leads to an increase in the risk of low-energy fractures, disability and mortality of GC users. Despite the few studies conducted in Ukraine on the epidemiology and treatment of GIOP, there have been no national recommendations for its management until now, which has become the background for their creation. The purpose was to develop national guidelines for the diagnosis, prevention, and treatment of GIOP based on the analytical analysis of modern literary sources to improve the awareness of the medical community of Ukraine, improve management, and reduce the socio-economic burden of the disease. Materials and methods. A group of 18 experts, leading Ukrainian scientists in various fields, was created to develop the guideline. An analysis of current literary sources on epidemiology, risk factors, diagnosis, prevention and treatment of GIOP, and monitoring of the effectiveness and safety of its treatment was carried out. Evidence was synthesized using the GRADE system, and a critical assessment of the quality of the recommendations was carried out using the AGREE II tool. Results. The guideline consists of 12 provisions on screening, diagnosis, prevention, and treatment of GIOP. The authors emphasized the need to increase the awareness of the medical community of Ukraine regarding the problem, as well as patients regarding the possible side effects of GC. They presented the features of the clinical assessment of the osteoporotic fracture risk in GC users, as well as modern and available in Ukraine methods of diagnosis and treatment of GIOP. Conclusion. The first Ukrainian guideline for screening, diagnosis, prevention, and treatment of GIOP is an important national tool for its management, which is recommended by the Board of the Ukrainian Association of Osteoporosis for use in practical health care by doctors of various specialties.https://pjs.zaslavsky.com.ua/index.php/journal/article/view/426glucocorticoid-induced osteoporosissecondary osteoporosisrecommendationspreventiontreatment |
| spellingShingle | N.V. Grygorieva V.M. Kovalenko М.О. Коrzh M.D. Tronko I.Yu. Golovach N.V. Dedukh D.G. Rekalov S.S. Strafun S.I. Smiyan O.A. Golubovska Ya.O. Dziublyk N.V. Kharchenko G.O. Protsenko O.O. Garmish V.L. Orlenko F.V. Klymovytsky А.S. Musiіenko T.A. Karasevska Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis Bolʹ, Sustavy, Pozvonočnik glucocorticoid-induced osteoporosis secondary osteoporosis recommendations prevention treatment |
| title | Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis |
| title_full | Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis |
| title_fullStr | Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis |
| title_full_unstemmed | Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis |
| title_short | Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis |
| title_sort | ukrainian guidelines for the prevention and treatment of glucocorticoid induced osteoporosis |
| topic | glucocorticoid-induced osteoporosis secondary osteoporosis recommendations prevention treatment |
| url | https://pjs.zaslavsky.com.ua/index.php/journal/article/view/426 |
| work_keys_str_mv | AT nvgrygorieva ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT vmkovalenko ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT mokorzh ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT mdtronko ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT iyugolovach ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT nvdedukh ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT dgrekalov ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT ssstrafun ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT sismiyan ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT oagolubovska ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT yaodziublyk ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT nvkharchenko ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT goprotsenko ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT oogarmish ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT vlorlenko ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT fvklymovytsky ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT asmusiíenko ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis AT takarasevska ukrainianguidelinesforthepreventionandtreatmentofglucocorticoidinducedosteoporosis |